nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—GLO1—melanoma	0.285	0.575	CbGaD
Indomethacin—ABCC6—Dactinomycin—melanoma	0.118	0.398	CbGbCtD
Indomethacin—CXCL8—melanoma	0.0847	0.171	CbGaD
Indomethacin—PPARG—melanoma	0.0585	0.118	CbGaD
Indomethacin—ABCC1—Vemurafenib—melanoma	0.0525	0.177	CbGbCtD
Indomethacin—ABCC1—Dactinomycin—melanoma	0.0349	0.117	CbGbCtD
Indomethacin—PTGS2—melanoma	0.0247	0.0498	CbGaD
Indomethacin—ALB—Vemurafenib—melanoma	0.0242	0.0816	CbGbCtD
Indomethacin—SLC22A7—Docetaxel—melanoma	0.023	0.0773	CbGbCtD
Indomethacin—ALB—melanoma	0.022	0.0444	CbGaD
Indomethacin—ABCB1—melanoma	0.021	0.0423	CbGaD
Indomethacin—ABCC1—Docetaxel—melanoma	0.018	0.0607	CbGbCtD
Indomethacin—ABCC2—Docetaxel—melanoma	0.0133	0.0449	CbGbCtD
Indomethacin—ABCB1—Dactinomycin—melanoma	0.00842	0.0284	CbGbCtD
Indomethacin—ABCC6—dermis—melanoma	0.00463	0.116	CbGeAlD
Indomethacin—ABCB1—Docetaxel—melanoma	0.00435	0.0146	CbGbCtD
Indomethacin—PPARG—dermis—melanoma	0.0024	0.0601	CbGeAlD
Indomethacin—SLC22A8—optic choroid—melanoma	0.00161	0.0403	CbGeAlD
Indomethacin—PPARG—leg—melanoma	0.00158	0.0397	CbGeAlD
Indomethacin—GLO1—hair follicle—melanoma	0.00151	0.0378	CbGeAlD
Indomethacin—PPARG—hindlimb—melanoma	0.00142	0.0354	CbGeAlD
Indomethacin—PPARA—blood vessel—melanoma	0.00123	0.0308	CbGeAlD
Indomethacin—PPARG—appendage—melanoma	0.00121	0.0304	CbGeAlD
Indomethacin—PPARA—neck—melanoma	0.000879	0.022	CbGeAlD
Indomethacin—PTGS2—leg—melanoma	0.00081	0.0203	CbGeAlD
Indomethacin—GLO1—eye—melanoma	0.000753	0.0189	CbGeAlD
Indomethacin—GLO1—retina—melanoma	0.000746	0.0187	CbGeAlD
Indomethacin—PPARG—endothelium—melanoma	0.000733	0.0184	CbGeAlD
Indomethacin—PTGS2—hindlimb—melanoma	0.000723	0.0181	CbGeAlD
Indomethacin—ABCC6—eye—melanoma	0.000693	0.0174	CbGeAlD
Indomethacin—PTGR2—head—melanoma	0.000692	0.0173	CbGeAlD
Indomethacin—ABCC6—retina—melanoma	0.000687	0.0172	CbGeAlD
Indomethacin—PPARG—blood vessel—melanoma	0.000676	0.0169	CbGeAlD
Indomethacin—Tolmetin—CXCL8—melanoma	0.000662	0.369	CrCbGaD
Indomethacin—GLO1—skin of body—melanoma	0.000655	0.0164	CbGeAlD
Indomethacin—PPARA—eye—melanoma	0.000654	0.0164	CbGeAlD
Indomethacin—CES1—neck—melanoma	0.000653	0.0163	CbGeAlD
Indomethacin—PPARA—retina—melanoma	0.000648	0.0162	CbGeAlD
Indomethacin—PTGS2—appendage—melanoma	0.00062	0.0155	CbGeAlD
Indomethacin—GLO1—mammalian vulva—melanoma	0.000598	0.015	CbGeAlD
Indomethacin—PPARA—skin of body—melanoma	0.000569	0.0143	CbGeAlD
Indomethacin—ABCC1—hair follicle—melanoma	0.000558	0.014	CbGeAlD
Indomethacin—PLA2G2A—mammalian vulva—melanoma	0.000556	0.0139	CbGeAlD
Indomethacin—PTGS2—skin epidermis—melanoma	0.000516	0.0129	CbGeAlD
Indomethacin—PTGR2—lymph node—melanoma	0.000485	0.0121	CbGeAlD
Indomethacin—PPARG—neck—melanoma	0.000484	0.0121	CbGeAlD
Indomethacin—AKR1C3—mammalian vulva—melanoma	0.000431	0.0108	CbGeAlD
Indomethacin—GLO1—head—melanoma	0.000428	0.0107	CbGeAlD
Indomethacin—PLA2G2A—head—melanoma	0.000398	0.00996	CbGeAlD
Indomethacin—ABCC6—head—melanoma	0.000394	0.00985	CbGeAlD
Indomethacin—PTGS1—endothelium—melanoma	0.000392	0.00981	CbGeAlD
Indomethacin—Bezafibrate—PPARG—melanoma	0.000376	0.21	CrCbGaD
Indomethacin—PTGS2—endothelium—melanoma	0.000375	0.00938	CbGeAlD
Indomethacin—PPARA—head—melanoma	0.000371	0.0093	CbGeAlD
Indomethacin—PTGS1—blood vessel—melanoma	0.000361	0.00905	CbGeAlD
Indomethacin—SLC10A1—head—melanoma	0.000357	0.00894	CbGeAlD
Indomethacin—PTGS2—blood vessel—melanoma	0.000345	0.00865	CbGeAlD
Indomethacin—SLC22A8—eye—melanoma	0.000324	0.00812	CbGeAlD
Indomethacin—PPARG—skin of body—melanoma	0.000313	0.00784	CbGeAlD
Indomethacin—GLO1—lymph node—melanoma	0.000299	0.0075	CbGeAlD
Indomethacin—Bromfenac—PTGS2—melanoma	0.000287	0.16	CrCbGaD
Indomethacin—PPARG—mammalian vulva—melanoma	0.000285	0.00715	CbGeAlD
Indomethacin—PLA2G2A—lymph node—melanoma	0.000278	0.00697	CbGeAlD
Indomethacin—CXCL8—lymph node—melanoma	0.000276	0.0069	CbGeAlD
Indomethacin—CES1—head—melanoma	0.000276	0.0069	CbGeAlD
Indomethacin—PPARA—lymph node—melanoma	0.00026	0.00651	CbGeAlD
Indomethacin—ABCC3—head—melanoma	0.000225	0.00563	CbGeAlD
Indomethacin—Colitis—Docetaxel—melanoma	0.000223	0.00341	CcSEcCtD
Indomethacin—Skin exfoliation—Docetaxel—melanoma	0.000222	0.00339	CcSEcCtD
Indomethacin—ABCC1—mammalian vulva—melanoma	0.000221	0.00553	CbGeAlD
Indomethacin—Haematuria—Bleomycin—melanoma	0.000221	0.00337	CcSEcCtD
Indomethacin—Abdominal distension—Temozolomide—melanoma	0.00022	0.00337	CcSEcCtD
Indomethacin—Fluid retention—Docetaxel—melanoma	0.00022	0.00337	CcSEcCtD
Indomethacin—AKR1C3—lymph node—melanoma	0.000216	0.00541	CbGeAlD
Indomethacin—Pancytopenia—Carmustine—melanoma	0.000215	0.00329	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000214	0.00327	CcSEcCtD
Indomethacin—ABCB1—blood vessel—melanoma	0.000214	0.00535	CbGeAlD
Indomethacin—Decreased appetite—Vemurafenib—melanoma	0.000212	0.00324	CcSEcCtD
Indomethacin—Stomatitis—Dactinomycin—melanoma	0.00021	0.00322	CcSEcCtD
Indomethacin—Fatigue—Vemurafenib—melanoma	0.00021	0.00321	CcSEcCtD
Indomethacin—Haemoglobin—Bleomycin—melanoma	0.000209	0.00319	CcSEcCtD
Indomethacin—Constipation—Vemurafenib—melanoma	0.000208	0.00319	CcSEcCtD
Indomethacin—Pancytopenia—Temozolomide—melanoma	0.000208	0.00318	CcSEcCtD
Indomethacin—Haemorrhage—Bleomycin—melanoma	0.000208	0.00318	CcSEcCtD
Indomethacin—Lightheadedness—Docetaxel—melanoma	0.000208	0.00318	CcSEcCtD
Indomethacin—Pulmonary oedema—Docetaxel—melanoma	0.000207	0.00316	CcSEcCtD
Indomethacin—Hyperglycaemia—Carmustine—melanoma	0.000204	0.00313	CcSEcCtD
Indomethacin—PPARG—head—melanoma	0.000204	0.00511	CbGeAlD
Indomethacin—Pollakiuria—Temozolomide—melanoma	0.000202	0.00309	CcSEcCtD
Indomethacin—Depression—Carmustine—melanoma	0.000201	0.00308	CcSEcCtD
Indomethacin—Agranulocytosis—Dactinomycin—melanoma	0.000201	0.00308	CcSEcCtD
Indomethacin—Weight increased—Temozolomide—melanoma	0.000199	0.00305	CcSEcCtD
Indomethacin—Renal failure—Carmustine—melanoma	0.000199	0.00304	CcSEcCtD
Indomethacin—Neuropathy peripheral—Carmustine—melanoma	0.000198	0.00303	CcSEcCtD
Indomethacin—Hyperglycaemia—Temozolomide—melanoma	0.000198	0.00302	CcSEcCtD
Indomethacin—Stomatitis—Carmustine—melanoma	0.000197	0.00301	CcSEcCtD
Indomethacin—Depression—Temozolomide—melanoma	0.000195	0.00298	CcSEcCtD
Indomethacin—Thrombophlebitis—Docetaxel—melanoma	0.000195	0.00298	CcSEcCtD
Indomethacin—Hepatitis—Dactinomycin—melanoma	0.000194	0.00296	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000194	0.00296	CcSEcCtD
Indomethacin—Tolmetin—PTGS2—melanoma	0.000193	0.108	CrCbGaD
Indomethacin—CES1—lymph node—melanoma	0.000193	0.00483	CbGeAlD
Indomethacin—Flushing—Bleomycin—melanoma	0.000193	0.00295	CcSEcCtD
Indomethacin—SLCO1A2—head—melanoma	0.000193	0.00482	CbGeAlD
Indomethacin—Body temperature increased—Vemurafenib—melanoma	0.000193	0.00295	CcSEcCtD
Indomethacin—Neuropathy peripheral—Temozolomide—melanoma	0.000191	0.00293	CcSEcCtD
Indomethacin—Stomatitis—Temozolomide—melanoma	0.00019	0.00291	CcSEcCtD
Indomethacin—Deafness—Docetaxel—melanoma	0.000188	0.00288	CcSEcCtD
Indomethacin—Cardiac failure congestive—Docetaxel—melanoma	0.000186	0.00284	CcSEcCtD
Indomethacin—ABCC4—head—melanoma	0.000185	0.00464	CbGeAlD
Indomethacin—SLC22A8—head—melanoma	0.000184	0.00461	CbGeAlD
Indomethacin—Alopecia—Bleomycin—melanoma	0.000184	0.00281	CcSEcCtD
Indomethacin—Erythema multiforme—Dactinomycin—melanoma	0.000183	0.0028	CcSEcCtD
Indomethacin—Haemoglobin—Carmustine—melanoma	0.000182	0.00279	CcSEcCtD
Indomethacin—Haemorrhage—Carmustine—melanoma	0.000181	0.00277	CcSEcCtD
Indomethacin—Erythema—Bleomycin—melanoma	0.000181	0.00277	CcSEcCtD
Indomethacin—Hot flush—Docetaxel—melanoma	0.00018	0.00275	CcSEcCtD
Indomethacin—Flushing—Dactinomycin—melanoma	0.00018	0.00275	CcSEcCtD
Indomethacin—Hypersensitivity—Vemurafenib—melanoma	0.00018	0.00274	CcSEcCtD
Indomethacin—Menopausal symptoms—Docetaxel—melanoma	0.000179	0.00273	CcSEcCtD
Indomethacin—Renal impairment—Docetaxel—melanoma	0.000177	0.00271	CcSEcCtD
Indomethacin—Haemoglobin—Temozolomide—melanoma	0.000176	0.00269	CcSEcCtD
Indomethacin—Hepatitis—Temozolomide—melanoma	0.000175	0.00268	CcSEcCtD
Indomethacin—Haemorrhage—Temozolomide—melanoma	0.000175	0.00268	CcSEcCtD
Indomethacin—Asthenia—Vemurafenib—melanoma	0.000175	0.00267	CcSEcCtD
Indomethacin—Pruritus—Vemurafenib—melanoma	0.000172	0.00264	CcSEcCtD
Indomethacin—Alopecia—Dactinomycin—melanoma	0.000171	0.00262	CcSEcCtD
Indomethacin—Hyponatraemia—Docetaxel—melanoma	0.000169	0.00259	CcSEcCtD
Indomethacin—Erythema—Dactinomycin—melanoma	0.000169	0.00258	CcSEcCtD
Indomethacin—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000168	0.00258	CcSEcCtD
Indomethacin—Flushing—Carmustine—melanoma	0.000168	0.00257	CcSEcCtD
Indomethacin—Ill-defined disorder—Bleomycin—melanoma	0.000168	0.00257	CcSEcCtD
Indomethacin—PTGS1—skin of body—melanoma	0.000167	0.00419	CbGeAlD
Indomethacin—Anaemia—Bleomycin—melanoma	0.000167	0.00256	CcSEcCtD
Indomethacin—Diarrhoea—Vemurafenib—melanoma	0.000167	0.00255	CcSEcCtD
Indomethacin—Erythema multiforme—Temozolomide—melanoma	0.000166	0.00253	CcSEcCtD
Indomethacin—Tinnitus—Temozolomide—melanoma	0.000163	0.0025	CcSEcCtD
Indomethacin—Malaise—Bleomycin—melanoma	0.000163	0.00249	CcSEcCtD
Indomethacin—Flushing—Temozolomide—melanoma	0.000163	0.00249	CcSEcCtD
Indomethacin—Arrhythmia—Carmustine—melanoma	0.000162	0.00248	CcSEcCtD
Indomethacin—Leukopenia—Bleomycin—melanoma	0.000162	0.00248	CcSEcCtD
Indomethacin—Dizziness—Vemurafenib—melanoma	0.000161	0.00246	CcSEcCtD
Indomethacin—Alopecia—Carmustine—melanoma	0.00016	0.00245	CcSEcCtD
Indomethacin—PTGS2—skin of body—melanoma	0.00016	0.004	CbGeAlD
Indomethacin—Erythema—Carmustine—melanoma	0.000158	0.00241	CcSEcCtD
Indomethacin—ABCC3—lymph node—melanoma	0.000157	0.00394	CbGeAlD
Indomethacin—Ill-defined disorder—Dactinomycin—melanoma	0.000157	0.00239	CcSEcCtD
Indomethacin—Anaemia—Dactinomycin—melanoma	0.000156	0.00238	CcSEcCtD
Indomethacin—Vomiting—Vemurafenib—melanoma	0.000155	0.00237	CcSEcCtD
Indomethacin—Alopecia—Temozolomide—melanoma	0.000155	0.00237	CcSEcCtD
Indomethacin—Chest pain—Bleomycin—melanoma	0.000154	0.00235	CcSEcCtD
Indomethacin—Abdominal pain upper—Docetaxel—melanoma	0.000154	0.00235	CcSEcCtD
Indomethacin—Rash—Vemurafenib—melanoma	0.000154	0.00235	CcSEcCtD
Indomethacin—Dermatitis—Vemurafenib—melanoma	0.000153	0.00235	CcSEcCtD
Indomethacin—Headache—Vemurafenib—melanoma	0.000153	0.00233	CcSEcCtD
Indomethacin—Erythema—Temozolomide—melanoma	0.000153	0.00233	CcSEcCtD
Indomethacin—PTGS1—mammalian vulva—melanoma	0.000153	0.00382	CbGeAlD
Indomethacin—Discomfort—Bleomycin—melanoma	0.000152	0.00233	CcSEcCtD
Indomethacin—Malaise—Dactinomycin—melanoma	0.000152	0.00233	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000152	0.00232	CcSEcCtD
Indomethacin—Leukopenia—Dactinomycin—melanoma	0.000151	0.00231	CcSEcCtD
Indomethacin—Confusional state—Bleomycin—melanoma	0.000149	0.00228	CcSEcCtD
Indomethacin—Vision blurred—Carmustine—melanoma	0.000149	0.00228	CcSEcCtD
Indomethacin—Oedema—Bleomycin—melanoma	0.000148	0.00226	CcSEcCtD
Indomethacin—Anaphylactic shock—Bleomycin—melanoma	0.000148	0.00226	CcSEcCtD
Indomethacin—Anaemia—Carmustine—melanoma	0.000146	0.00223	CcSEcCtD
Indomethacin—Naproxen—PTGS2—melanoma	0.000145	0.081	CrCbGaD
Indomethacin—Nausea—Vemurafenib—melanoma	0.000145	0.00221	CcSEcCtD
Indomethacin—Thrombocytopenia—Bleomycin—melanoma	0.000145	0.00221	CcSEcCtD
Indomethacin—Vision blurred—Temozolomide—melanoma	0.000144	0.0022	CcSEcCtD
Indomethacin—PPARG—lymph node—melanoma	0.000143	0.00358	CbGeAlD
Indomethacin—Discomfort—Dactinomycin—melanoma	0.000142	0.00217	CcSEcCtD
Indomethacin—Ill-defined disorder—Temozolomide—melanoma	0.000142	0.00216	CcSEcCtD
Indomethacin—Leukopenia—Carmustine—melanoma	0.000141	0.00216	CcSEcCtD
Indomethacin—Anaemia—Temozolomide—melanoma	0.000141	0.00216	CcSEcCtD
Indomethacin—Anorexia—Bleomycin—melanoma	0.000141	0.00215	CcSEcCtD
Indomethacin—Angioedema—Temozolomide—melanoma	0.000139	0.00213	CcSEcCtD
Indomethacin—Pancytopenia—Docetaxel—melanoma	0.000138	0.00211	CcSEcCtD
Indomethacin—Hypotension—Bleomycin—melanoma	0.000138	0.00211	CcSEcCtD
Indomethacin—Oedema—Dactinomycin—melanoma	0.000138	0.00211	CcSEcCtD
Indomethacin—Malaise—Temozolomide—melanoma	0.000138	0.0021	CcSEcCtD
Indomethacin—Vertigo—Temozolomide—melanoma	0.000137	0.0021	CcSEcCtD
Indomethacin—Convulsion—Carmustine—melanoma	0.000137	0.00209	CcSEcCtD
Indomethacin—Leukopenia—Temozolomide—melanoma	0.000137	0.00209	CcSEcCtD
Indomethacin—Hypertension—Carmustine—melanoma	0.000136	0.00208	CcSEcCtD
Indomethacin—Palpitations—Temozolomide—melanoma	0.000135	0.00206	CcSEcCtD
Indomethacin—Thrombocytopenia—Dactinomycin—melanoma	0.000135	0.00206	CcSEcCtD
Indomethacin—Chest pain—Carmustine—melanoma	0.000134	0.00206	CcSEcCtD
Indomethacin—ALB—lymph node—melanoma	0.000134	0.00336	CbGeAlD
Indomethacin—Anxiety—Carmustine—melanoma	0.000134	0.00205	CcSEcCtD
Indomethacin—Paraesthesia—Bleomycin—melanoma	0.000133	0.00203	CcSEcCtD
Indomethacin—Weight increased—Docetaxel—melanoma	0.000133	0.00203	CcSEcCtD
Indomethacin—Convulsion—Temozolomide—melanoma	0.000132	0.00202	CcSEcCtD
Indomethacin—Hypertension—Temozolomide—melanoma	0.000132	0.00201	CcSEcCtD
Indomethacin—Dyspnoea—Bleomycin—melanoma	0.000132	0.00201	CcSEcCtD
Indomethacin—Anorexia—Dactinomycin—melanoma	0.000131	0.00201	CcSEcCtD
Indomethacin—Confusional state—Carmustine—melanoma	0.00013	0.00199	CcSEcCtD
Indomethacin—ABCC4—lymph node—melanoma	0.00013	0.00325	CbGeAlD
Indomethacin—Naproxen—ALB—melanoma	0.000129	0.0722	CrCbGaD
Indomethacin—Anxiety—Temozolomide—melanoma	0.000129	0.00198	CcSEcCtD
Indomethacin—Oedema—Carmustine—melanoma	0.000129	0.00197	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000129	0.00197	CcSEcCtD
Indomethacin—Discomfort—Temozolomide—melanoma	0.000128	0.00196	CcSEcCtD
Indomethacin—Decreased appetite—Bleomycin—melanoma	0.000128	0.00196	CcSEcCtD
Indomethacin—Renal failure—Docetaxel—melanoma	0.000128	0.00195	CcSEcCtD
Indomethacin—Neuropathy peripheral—Docetaxel—melanoma	0.000127	0.00195	CcSEcCtD
Indomethacin—Jaundice—Docetaxel—melanoma	0.000127	0.00194	CcSEcCtD
Indomethacin—Stomatitis—Docetaxel—melanoma	0.000127	0.00194	CcSEcCtD
Indomethacin—Pain—Bleomycin—melanoma	0.000126	0.00193	CcSEcCtD
Indomethacin—Thrombocytopenia—Carmustine—melanoma	0.000126	0.00193	CcSEcCtD
Indomethacin—Tachycardia—Carmustine—melanoma	0.000126	0.00192	CcSEcCtD
Indomethacin—ABCC2—lymph node—melanoma	0.000126	0.00315	CbGeAlD
Indomethacin—Confusional state—Temozolomide—melanoma	0.000126	0.00192	CcSEcCtD
Indomethacin—Oedema—Temozolomide—melanoma	0.000125	0.0019	CcSEcCtD
Indomethacin—Anaphylactic shock—Temozolomide—melanoma	0.000125	0.0019	CcSEcCtD
Indomethacin—Anorexia—Carmustine—melanoma	0.000123	0.00188	CcSEcCtD
Indomethacin—Epistaxis—Docetaxel—melanoma	0.000122	0.00187	CcSEcCtD
Indomethacin—Thrombocytopenia—Temozolomide—melanoma	0.000122	0.00186	CcSEcCtD
Indomethacin—Feeling abnormal—Bleomycin—melanoma	0.000122	0.00186	CcSEcCtD
Indomethacin—Agranulocytosis—Docetaxel—melanoma	0.000121	0.00185	CcSEcCtD
Indomethacin—Hypotension—Carmustine—melanoma	0.00012	0.00184	CcSEcCtD
Indomethacin—Hyperhidrosis—Temozolomide—melanoma	0.00012	0.00184	CcSEcCtD
Indomethacin—Decreased appetite—Dactinomycin—melanoma	0.00012	0.00183	CcSEcCtD
Indomethacin—Fatigue—Dactinomycin—melanoma	0.000119	0.00181	CcSEcCtD
Indomethacin—Anorexia—Temozolomide—melanoma	0.000119	0.00181	CcSEcCtD
Indomethacin—Pain—Dactinomycin—melanoma	0.000118	0.0018	CcSEcCtD
Indomethacin—Urticaria—Bleomycin—melanoma	0.000117	0.00179	CcSEcCtD
Indomethacin—Haemoglobin—Docetaxel—melanoma	0.000117	0.00179	CcSEcCtD
Indomethacin—Body temperature increased—Bleomycin—melanoma	0.000117	0.00178	CcSEcCtD
Indomethacin—Hepatitis—Docetaxel—melanoma	0.000117	0.00178	CcSEcCtD
Indomethacin—Haemorrhage—Docetaxel—melanoma	0.000117	0.00178	CcSEcCtD
Indomethacin—Insomnia—Carmustine—melanoma	0.000117	0.00178	CcSEcCtD
Indomethacin—Paraesthesia—Carmustine—melanoma	0.000116	0.00177	CcSEcCtD
Indomethacin—Dyspnoea—Carmustine—melanoma	0.000115	0.00176	CcSEcCtD
Indomethacin—Somnolence—Carmustine—melanoma	0.000115	0.00175	CcSEcCtD
Indomethacin—Feeling abnormal—Dactinomycin—melanoma	0.000113	0.00173	CcSEcCtD
Indomethacin—ABCB1—retina—melanoma	0.000113	0.00282	CbGeAlD
Indomethacin—Insomnia—Temozolomide—melanoma	0.000113	0.00172	CcSEcCtD
Indomethacin—Gastrointestinal pain—Dactinomycin—melanoma	0.000113	0.00172	CcSEcCtD
Indomethacin—Decreased appetite—Carmustine—melanoma	0.000112	0.00171	CcSEcCtD
Indomethacin—Paraesthesia—Temozolomide—melanoma	0.000112	0.00171	CcSEcCtD
Indomethacin—Dyspnoea—Temozolomide—melanoma	0.000111	0.0017	CcSEcCtD
Indomethacin—Somnolence—Temozolomide—melanoma	0.000111	0.00169	CcSEcCtD
Indomethacin—ABCC1—lymph node—melanoma	0.000111	0.00277	CbGeAlD
Indomethacin—Erythema multiforme—Docetaxel—melanoma	0.00011	0.00169	CcSEcCtD
Indomethacin—Pain—Carmustine—melanoma	0.00011	0.00168	CcSEcCtD
Indomethacin—Constipation—Carmustine—melanoma	0.00011	0.00168	CcSEcCtD
Indomethacin—Dyspepsia—Temozolomide—melanoma	0.00011	0.00168	CcSEcCtD
Indomethacin—PTGS1—head—melanoma	0.000109	0.00273	CbGeAlD
Indomethacin—Abdominal pain—Dactinomycin—melanoma	0.000109	0.00166	CcSEcCtD
Indomethacin—Body temperature increased—Dactinomycin—melanoma	0.000109	0.00166	CcSEcCtD
Indomethacin—Hypersensitivity—Bleomycin—melanoma	0.000109	0.00166	CcSEcCtD
Indomethacin—Decreased appetite—Temozolomide—melanoma	0.000108	0.00166	CcSEcCtD
Indomethacin—Flushing—Docetaxel—melanoma	0.000108	0.00165	CcSEcCtD
Indomethacin—Fatigue—Temozolomide—melanoma	0.000107	0.00164	CcSEcCtD
Indomethacin—Constipation—Temozolomide—melanoma	0.000106	0.00163	CcSEcCtD
Indomethacin—Pain—Temozolomide—melanoma	0.000106	0.00163	CcSEcCtD
Indomethacin—Feeling abnormal—Carmustine—melanoma	0.000106	0.00162	CcSEcCtD
Indomethacin—Asthenia—Bleomycin—melanoma	0.000106	0.00162	CcSEcCtD
Indomethacin—Gastrointestinal pain—Carmustine—melanoma	0.000105	0.00161	CcSEcCtD
Indomethacin—Pruritus—Bleomycin—melanoma	0.000104	0.0016	CcSEcCtD
Indomethacin—PTGS2—head—melanoma	0.000104	0.00261	CbGeAlD
Indomethacin—Arrhythmia—Docetaxel—melanoma	0.000104	0.00159	CcSEcCtD
Indomethacin—Alopecia—Docetaxel—melanoma	0.000103	0.00157	CcSEcCtD
Indomethacin—Feeling abnormal—Temozolomide—melanoma	0.000103	0.00157	CcSEcCtD
Indomethacin—Body temperature increased—Carmustine—melanoma	0.000102	0.00156	CcSEcCtD
Indomethacin—Abdominal pain—Carmustine—melanoma	0.000102	0.00156	CcSEcCtD
Indomethacin—Gastrointestinal pain—Temozolomide—melanoma	0.000102	0.00156	CcSEcCtD
Indomethacin—Erythema—Docetaxel—melanoma	0.000101	0.00155	CcSEcCtD
Indomethacin—Hypersensitivity—Dactinomycin—melanoma	0.000101	0.00155	CcSEcCtD
Indomethacin—Urticaria—Temozolomide—melanoma	9.89e-05	0.00151	CcSEcCtD
Indomethacin—Asthenia—Dactinomycin—melanoma	9.88e-05	0.00151	CcSEcCtD
Indomethacin—Body temperature increased—Temozolomide—melanoma	9.84e-05	0.00151	CcSEcCtD
Indomethacin—Abdominal pain—Temozolomide—melanoma	9.84e-05	0.00151	CcSEcCtD
Indomethacin—Hypersensitivity—Carmustine—melanoma	9.49e-05	0.00145	CcSEcCtD
Indomethacin—Diarrhoea—Dactinomycin—melanoma	9.42e-05	0.00144	CcSEcCtD
Indomethacin—Vomiting—Bleomycin—melanoma	9.39e-05	0.00144	CcSEcCtD
Indomethacin—Anaemia—Docetaxel—melanoma	9.38e-05	0.00143	CcSEcCtD
Indomethacin—Rash—Bleomycin—melanoma	9.31e-05	0.00142	CcSEcCtD
Indomethacin—Dermatitis—Bleomycin—melanoma	9.3e-05	0.00142	CcSEcCtD
Indomethacin—Asthenia—Carmustine—melanoma	9.25e-05	0.00141	CcSEcCtD
Indomethacin—Hypersensitivity—Temozolomide—melanoma	9.17e-05	0.0014	CcSEcCtD
Indomethacin—Syncope—Docetaxel—melanoma	9.1e-05	0.00139	CcSEcCtD
Indomethacin—Leukopenia—Docetaxel—melanoma	9.08e-05	0.00139	CcSEcCtD
Indomethacin—ABCB1—mammalian vulva—melanoma	9.02e-05	0.00226	CbGeAlD
Indomethacin—Palpitations—Docetaxel—melanoma	8.97e-05	0.00137	CcSEcCtD
Indomethacin—Asthenia—Temozolomide—melanoma	8.93e-05	0.00137	CcSEcCtD
Indomethacin—Loss of consciousness—Docetaxel—melanoma	8.92e-05	0.00136	CcSEcCtD
Indomethacin—Diarrhoea—Carmustine—melanoma	8.82e-05	0.00135	CcSEcCtD
Indomethacin—Pruritus—Temozolomide—melanoma	8.81e-05	0.00135	CcSEcCtD
Indomethacin—Convulsion—Docetaxel—melanoma	8.79e-05	0.00134	CcSEcCtD
Indomethacin—Nausea—Bleomycin—melanoma	8.77e-05	0.00134	CcSEcCtD
Indomethacin—Hypertension—Docetaxel—melanoma	8.76e-05	0.00134	CcSEcCtD
Indomethacin—Vomiting—Dactinomycin—melanoma	8.75e-05	0.00134	CcSEcCtD
Indomethacin—Rash—Dactinomycin—melanoma	8.68e-05	0.00133	CcSEcCtD
Indomethacin—Chest pain—Docetaxel—melanoma	8.64e-05	0.00132	CcSEcCtD
Indomethacin—Dizziness—Carmustine—melanoma	8.52e-05	0.0013	CcSEcCtD
Indomethacin—Diarrhoea—Temozolomide—melanoma	8.52e-05	0.0013	CcSEcCtD
Indomethacin—Confusional state—Docetaxel—melanoma	8.35e-05	0.00128	CcSEcCtD
Indomethacin—Anaphylactic shock—Docetaxel—melanoma	8.28e-05	0.00127	CcSEcCtD
Indomethacin—Oedema—Docetaxel—melanoma	8.28e-05	0.00127	CcSEcCtD
Indomethacin—Dizziness—Temozolomide—melanoma	8.23e-05	0.00126	CcSEcCtD
Indomethacin—Vomiting—Carmustine—melanoma	8.19e-05	0.00125	CcSEcCtD
Indomethacin—Nausea—Dactinomycin—melanoma	8.18e-05	0.00125	CcSEcCtD
Indomethacin—Shock—Docetaxel—melanoma	8.15e-05	0.00125	CcSEcCtD
Indomethacin—Rash—Carmustine—melanoma	8.12e-05	0.00124	CcSEcCtD
Indomethacin—Dermatitis—Carmustine—melanoma	8.12e-05	0.00124	CcSEcCtD
Indomethacin—Thrombocytopenia—Docetaxel—melanoma	8.11e-05	0.00124	CcSEcCtD
Indomethacin—Tachycardia—Docetaxel—melanoma	8.08e-05	0.00124	CcSEcCtD
Indomethacin—Headache—Carmustine—melanoma	8.07e-05	0.00123	CcSEcCtD
Indomethacin—Vomiting—Temozolomide—melanoma	7.92e-05	0.00121	CcSEcCtD
Indomethacin—Anorexia—Docetaxel—melanoma	7.89e-05	0.00121	CcSEcCtD
Indomethacin—Rash—Temozolomide—melanoma	7.85e-05	0.0012	CcSEcCtD
Indomethacin—Dermatitis—Temozolomide—melanoma	7.84e-05	0.0012	CcSEcCtD
Indomethacin—Headache—Temozolomide—melanoma	7.8e-05	0.00119	CcSEcCtD
Indomethacin—Hypotension—Docetaxel—melanoma	7.74e-05	0.00118	CcSEcCtD
Indomethacin—Nausea—Carmustine—melanoma	7.65e-05	0.00117	CcSEcCtD
Indomethacin—PTGS1—lymph node—melanoma	7.64e-05	0.00191	CbGeAlD
Indomethacin—Insomnia—Docetaxel—melanoma	7.49e-05	0.00115	CcSEcCtD
Indomethacin—Paraesthesia—Docetaxel—melanoma	7.44e-05	0.00114	CcSEcCtD
Indomethacin—Nausea—Temozolomide—melanoma	7.4e-05	0.00113	CcSEcCtD
Indomethacin—Dyspnoea—Docetaxel—melanoma	7.38e-05	0.00113	CcSEcCtD
Indomethacin—Somnolence—Docetaxel—melanoma	7.36e-05	0.00113	CcSEcCtD
Indomethacin—PTGS2—lymph node—melanoma	7.31e-05	0.00183	CbGeAlD
Indomethacin—Dyspepsia—Docetaxel—melanoma	7.29e-05	0.00111	CcSEcCtD
Indomethacin—Decreased appetite—Docetaxel—melanoma	7.2e-05	0.0011	CcSEcCtD
Indomethacin—Fatigue—Docetaxel—melanoma	7.14e-05	0.00109	CcSEcCtD
Indomethacin—Pain—Docetaxel—melanoma	7.08e-05	0.00108	CcSEcCtD
Indomethacin—Constipation—Docetaxel—melanoma	7.08e-05	0.00108	CcSEcCtD
Indomethacin—Feeling abnormal—Docetaxel—melanoma	6.82e-05	0.00104	CcSEcCtD
Indomethacin—Gastrointestinal pain—Docetaxel—melanoma	6.77e-05	0.00104	CcSEcCtD
Indomethacin—Body temperature increased—Docetaxel—melanoma	6.55e-05	0.001	CcSEcCtD
Indomethacin—Abdominal pain—Docetaxel—melanoma	6.55e-05	0.001	CcSEcCtD
Indomethacin—ABCB1—head—melanoma	6.45e-05	0.00162	CbGeAlD
Indomethacin—Hypersensitivity—Docetaxel—melanoma	6.1e-05	0.000933	CcSEcCtD
Indomethacin—Asthenia—Docetaxel—melanoma	5.94e-05	0.000908	CcSEcCtD
Indomethacin—Pruritus—Docetaxel—melanoma	5.86e-05	0.000896	CcSEcCtD
Indomethacin—Diarrhoea—Docetaxel—melanoma	5.67e-05	0.000866	CcSEcCtD
Indomethacin—Dizziness—Docetaxel—melanoma	5.48e-05	0.000837	CcSEcCtD
Indomethacin—Vomiting—Docetaxel—melanoma	5.27e-05	0.000805	CcSEcCtD
Indomethacin—Rash—Docetaxel—melanoma	5.22e-05	0.000798	CcSEcCtD
Indomethacin—Dermatitis—Docetaxel—melanoma	5.22e-05	0.000798	CcSEcCtD
Indomethacin—Headache—Docetaxel—melanoma	5.19e-05	0.000793	CcSEcCtD
Indomethacin—Nausea—Docetaxel—melanoma	4.92e-05	0.000752	CcSEcCtD
Indomethacin—ABCB1—lymph node—melanoma	4.52e-05	0.00113	CbGeAlD
Indomethacin—PTGS2—Metabolism—ABCB1—melanoma	2.08e-06	2.08e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—ERBB2—melanoma	2.07e-06	2.07e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.06e-06	2.07e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CB—melanoma	2.06e-06	2.07e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GNA11—melanoma	2.05e-06	2.06e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CDKN1B—melanoma	2.05e-06	2.06e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MAPK3—melanoma	2.05e-06	2.05e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PPARG—melanoma	2.04e-06	2.05e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—melanoma	2.04e-06	2.05e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CB—melanoma	2.04e-06	2.05e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP1B1—melanoma	2.04e-06	2.04e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CD4—melanoma	2.04e-06	2.04e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CD—melanoma	2.03e-06	2.04e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CD—melanoma	2.03e-06	2.04e-05	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—AKT1—melanoma	2.03e-06	2.04e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HIF1A—melanoma	2.03e-06	2.03e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PIK3CA—melanoma	2.02e-06	2.03e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—melanoma	2.02e-06	2.03e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CASP3—melanoma	2.01e-06	2.02e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—FASN—melanoma	2.01e-06	2.02e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL2—melanoma	2.01e-06	2.01e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ALB—melanoma	2.01e-06	2.01e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ALB—melanoma	2.01e-06	2.01e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GNA11—melanoma	2e-06	2.01e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL6—melanoma	2e-06	2e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MYC—melanoma	1.99e-06	2e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP17A1—melanoma	1.98e-06	1.99e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SLC5A5—melanoma	1.98e-06	1.98e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.98e-06	1.98e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—AKT1—melanoma	1.97e-06	1.98e-05	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.97e-06	1.97e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—FASN—melanoma	1.96e-06	1.97e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CD—melanoma	1.96e-06	1.96e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCND1—melanoma	1.96e-06	1.96e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MAPK3—melanoma	1.96e-06	1.96e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.96e-06	1.96e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MAPK1—melanoma	1.95e-06	1.95e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—EGFR—melanoma	1.95e-06	1.95e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CTNNB1—melanoma	1.94e-06	1.95e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ALB—melanoma	1.93e-06	1.94e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.93e-06	1.94e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SLC5A5—melanoma	1.93e-06	1.93e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—AKT1—melanoma	1.92e-06	1.93e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CDKN1B—melanoma	1.91e-06	1.92e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PRKCA—melanoma	1.91e-06	1.92e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CD44—melanoma	1.91e-06	1.91e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GNAQ—melanoma	1.91e-06	1.91e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MYC—melanoma	1.9e-06	1.91e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MMP9—melanoma	1.9e-06	1.91e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CB—melanoma	1.9e-06	1.9e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CDKN1A—melanoma	1.9e-06	1.9e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ERCC2—melanoma	1.89e-06	1.9e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PTEN—melanoma	1.89e-06	1.9e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CG—melanoma	1.88e-06	1.89e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTEN—melanoma	1.88e-06	1.89e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTEN—melanoma	1.88e-06	1.89e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NFKB1—melanoma	1.88e-06	1.89e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—melanoma	1.88e-06	1.89e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GNA11—melanoma	1.87e-06	1.88e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.87e-06	1.87e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GNAQ—melanoma	1.86e-06	1.87e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CD44—melanoma	1.86e-06	1.87e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CD—melanoma	1.86e-06	1.87e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.85e-06	1.86e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AKT1—melanoma	1.84e-06	1.85e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOS2—melanoma	1.84e-06	1.85e-05	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—AKT1—melanoma	1.84e-06	1.85e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KRAS—melanoma	1.84e-06	1.85e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ALB—melanoma	1.84e-06	1.84e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—FASN—melanoma	1.83e-06	1.84e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP1B1—melanoma	1.83e-06	1.84e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOTCH1—melanoma	1.83e-06	1.83e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PPARG—melanoma	1.82e-06	1.82e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CTNNB1—melanoma	1.81e-06	1.81e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC5A5—melanoma	1.8e-06	1.81e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.8e-06	1.8e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CD80—melanoma	1.79e-06	1.79e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP1B1—melanoma	1.79e-06	1.79e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KIT—melanoma	1.79e-06	1.79e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APC—melanoma	1.79e-06	1.79e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—melanoma	1.79e-06	1.79e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTEN—melanoma	1.78e-06	1.79e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CB—melanoma	1.77e-06	1.78e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CB—melanoma	1.77e-06	1.78e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CDKN1A—melanoma	1.77e-06	1.77e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGF—melanoma	1.77e-06	1.77e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—NRAS—melanoma	1.76e-06	1.77e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTEN—melanoma	1.76e-06	1.77e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—melanoma	1.76e-06	1.76e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—melanoma	1.76e-06	1.76e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PIK3CA—melanoma	1.75e-06	1.76e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GNAQ—melanoma	1.74e-06	1.75e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CD44—melanoma	1.74e-06	1.75e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CB—melanoma	1.71e-06	1.71e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—melanoma	1.71e-06	1.71e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.7e-06	1.71e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—melanoma	1.69e-06	1.7e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—STAT3—melanoma	1.69e-06	1.7e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PIK3CA—melanoma	1.69e-06	1.7e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.69e-06	1.69e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—MAPK3—melanoma	1.69e-06	1.69e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NRAS—melanoma	1.69e-06	1.69e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—BRAF—melanoma	1.68e-06	1.68e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ABCB1—melanoma	1.68e-06	1.68e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP1B1—melanoma	1.67e-06	1.67e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CD—melanoma	1.66e-06	1.66e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AKT1—melanoma	1.65e-06	1.66e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTEN—melanoma	1.64e-06	1.64e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—melanoma	1.64e-06	1.64e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ALB—melanoma	1.64e-06	1.64e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CB—melanoma	1.62e-06	1.63e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK3—melanoma	1.62e-06	1.62e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.62e-06	1.62e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—melanoma	1.61e-06	1.61e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—MAPK1—melanoma	1.61e-06	1.61e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAP2K1—melanoma	1.58e-06	1.59e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—STAT3—melanoma	1.58e-06	1.58e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NRAS—melanoma	1.57e-06	1.58e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MYC—melanoma	1.57e-06	1.58e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CD—melanoma	1.57e-06	1.57e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.57e-06	1.57e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HRAS—melanoma	1.56e-06	1.57e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PRKCA—melanoma	1.55e-06	1.55e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK1—melanoma	1.54e-06	1.54e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EGFR—melanoma	1.54e-06	1.54e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ERCC2—melanoma	1.53e-06	1.54e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTEN—melanoma	1.53e-06	1.53e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTEN—melanoma	1.53e-06	1.53e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—KRAS—melanoma	1.52e-06	1.52e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ABCB1—melanoma	1.51e-06	1.51e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MAPK3—melanoma	1.51e-06	1.51e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—FGF2—melanoma	1.5e-06	1.51e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—melanoma	1.5e-06	1.5e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CG—melanoma	1.5e-06	1.5e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTEN—melanoma	1.48e-06	1.48e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.47e-06	1.48e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MYC—melanoma	1.46e-06	1.47e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KRAS—melanoma	1.45e-06	1.46e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CB—melanoma	1.44e-06	1.45e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPARG—melanoma	1.44e-06	1.45e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MAPK1—melanoma	1.43e-06	1.44e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EGFR—melanoma	1.43e-06	1.44e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AKT1—melanoma	1.43e-06	1.44e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—melanoma	1.43e-06	1.43e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MDM2—melanoma	1.41e-06	1.41e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTEN—melanoma	1.4e-06	1.41e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PIK3CA—melanoma	1.39e-06	1.4e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PRKCA—melanoma	1.39e-06	1.39e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ERBB2—melanoma	1.39e-06	1.39e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT1—melanoma	1.38e-06	1.39e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ERCC2—melanoma	1.38e-06	1.38e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ABCB1—melanoma	1.37e-06	1.38e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CB—melanoma	1.37e-06	1.37e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CD4—melanoma	1.37e-06	1.37e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PRKCA—melanoma	1.35e-06	1.36e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KRAS—melanoma	1.35e-06	1.36e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—melanoma	1.35e-06	1.35e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ERCC2—melanoma	1.34e-06	1.35e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PIK3CA—melanoma	1.33e-06	1.34e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PIK3CA—melanoma	1.33e-06	1.33e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PIK3CA—melanoma	1.33e-06	1.33e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—AKT1—melanoma	1.32e-06	1.32e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CD—melanoma	1.32e-06	1.32e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ALB—melanoma	1.3e-06	1.3e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—melanoma	1.29e-06	1.29e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—HRAS—melanoma	1.29e-06	1.29e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDKN1B—melanoma	1.28e-06	1.29e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.27e-06	1.27e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PRKCA—melanoma	1.26e-06	1.27e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CA—melanoma	1.26e-06	1.26e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ERCC2—melanoma	1.25e-06	1.26e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTEN—melanoma	1.25e-06	1.25e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CA—melanoma	1.24e-06	1.25e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HRAS—melanoma	1.23e-06	1.24e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CTNNB1—melanoma	1.21e-06	1.22e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CG—melanoma	1.21e-06	1.21e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDKN1A—melanoma	1.19e-06	1.19e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PTEN—melanoma	1.18e-06	1.19e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—melanoma	1.18e-06	1.18e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARG—melanoma	1.17e-06	1.17e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CA—melanoma	1.16e-06	1.16e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HRAS—melanoma	1.15e-06	1.15e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CB—melanoma	1.15e-06	1.15e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.14e-06	1.14e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT1—melanoma	1.14e-06	1.14e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—melanoma	1.1e-06	1.1e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT1—melanoma	1.09e-06	1.09e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CG—melanoma	1.09e-06	1.09e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AKT1—melanoma	1.09e-06	1.09e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AKT1—melanoma	1.09e-06	1.09e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CA—melanoma	1.08e-06	1.08e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CA—melanoma	1.08e-06	1.08e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CD—melanoma	1.06e-06	1.07e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CG—melanoma	1.06e-06	1.06e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—STAT3—melanoma	1.06e-06	1.06e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NRAS—melanoma	1.06e-06	1.06e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARG—melanoma	1.05e-06	1.05e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CA—melanoma	1.04e-06	1.04e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.04e-06	1.04e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AKT1—melanoma	1.03e-06	1.03e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARG—melanoma	1.02e-06	1.03e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT1—melanoma	1.02e-06	1.02e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAPK3—melanoma	1.01e-06	1.01e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CG—melanoma	9.91e-07	9.93e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PTEN—melanoma	9.91e-07	9.93e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CA—melanoma	9.9e-07	9.92e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MYC—melanoma	9.83e-07	9.86e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAPK1—melanoma	9.62e-07	9.64e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGFR—melanoma	9.61e-07	9.64e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARG—melanoma	9.56e-07	9.59e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CD—melanoma	9.55e-07	9.58e-06	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AKT1—melanoma	9.45e-07	9.48e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ALB—melanoma	9.43e-07	9.45e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CD—melanoma	9.32e-07	9.35e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CB—melanoma	9.27e-07	9.3e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ALB—melanoma	9.2e-07	9.23e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—melanoma	9.19e-07	9.21e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KRAS—melanoma	9.08e-07	9.11e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AKT1—melanoma	8.82e-07	8.85e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AKT1—melanoma	8.82e-07	8.85e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CA—melanoma	8.8e-07	8.83e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CD—melanoma	8.71e-07	8.73e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ALB—melanoma	8.6e-07	8.62e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AKT1—melanoma	8.51e-07	8.53e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CA—melanoma	8.34e-07	8.37e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CB—melanoma	8.33e-07	8.35e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—melanoma	8.25e-07	8.27e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CB—melanoma	8.13e-07	8.15e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AKT1—melanoma	8.08e-07	8.11e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—melanoma	8.05e-07	8.07e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTEN—melanoma	8.01e-07	8.04e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HRAS—melanoma	7.72e-07	7.74e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CB—melanoma	7.59e-07	7.61e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—melanoma	7.52e-07	7.54e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—melanoma	7.39e-07	7.41e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTEN—melanoma	7.19e-07	7.21e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AKT1—melanoma	7.19e-07	7.21e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTEN—melanoma	7.02e-07	7.04e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CA—melanoma	6.99e-07	7.01e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT1—melanoma	6.82e-07	6.83e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTEN—melanoma	6.56e-07	6.58e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKT1—melanoma	5.71e-07	5.72e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CA—melanoma	5.65e-07	5.67e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CA—melanoma	5.08e-07	5.09e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CA—melanoma	4.95e-07	4.97e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CA—melanoma	4.63e-07	4.64e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKT1—melanoma	4.62e-07	4.63e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKT1—melanoma	4.15e-07	4.16e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKT1—melanoma	4.05e-07	4.06e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKT1—melanoma	3.78e-07	3.79e-06	CbGpPWpGaD
